Australia - English - Department of Health (Therapeutic Goods Administration)

sigma company limited - zinc oxide, quantity: 9.34 mg (equivalent: zinc, qty 7.5 mg); colecalciferol, quantity: 12.5 microgram; heavy magnesium oxide, quantity: 82.92 mg (equivalent: magnesium, qty 50 mg); calcium carbonate, quantity: 1.5 g; cupric sulfate pentahydrate, quantity: 3.93 mg (equivalent: copper, qty 1 mg); manganese sulfate monohydrate, quantity: 5.54 mg (equivalent: manganese, qty 1.8 mg) - tablet, film coated - excipient ingredients: triacetin; hypromellose; calcium carbonate; povidone; magnesium stearate; ethylcellulose; croscarmellose sodium; colloidal anhydrous silica; purified talc; erythrosine aluminium lake; microcrystalline cellulose - maintain/support healthy teeth ; maintain/support teeth strength ; maintain/support bone health ; maintain/support bone strength ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support absorption of dietary (state vitamin/mineral/nutrient)

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37) - zinc cation 25 mg - zinc acetate therapy is indicated for maintenance treatment of patients with wilson’s disease who have been initially treated with a chelating agent (see precautions: monitoring patients). zinc acetate capsules are contraindicated in patients with known hypersensitivity to any of the components of the formulation.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - amiodarone hydrochloride - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - amiodarone hydrochloride - oral tablet - 200mg

Canada - English - Health Canada

sivem pharmaceuticals ulc - amiodarone hydrochloride - tablet - 200mg - amiodarone hydrochloride 200mg - class iii antiarrythmics

Canada - English - Health Canada

mylan pharmaceuticals ulc - amiodarone hydrochloride - solution - 50mg - amiodarone hydrochloride 50mg - class iii antiarrythmics

Canada - English - Health Canada

jamp pharma corporation - amiodarone hydrochloride - solution - 50mg - amiodarone hydrochloride 50mg - class iii antiarrythmics

United States - English - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - parathyroid hormone (unii: n19a0t0e5j) (parathyroid hormone - unii:n19a0t0e5j) - parathyroid hormone 25 ug in 0.08 ml - natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism. limitations of use - because of the potential risk of osteosarcoma, natpara is recommended only for patients who cannot be well-controlled on calcium supplements and active forms of vitamin d alone [see warnings and precautions (5.1)] . - natpara was not studied in patients with hypoparathyroidism caused by calcium-sensing receptor mutations. - natpara was not studied in patients with acute post-surgical hypoparathyroidism. natpara is contraindicated in patients with a known hypersensitivity to any component of this product. hypersensitivity reactions (e.g., anaphylaxis, angioedema, and urticaria) have occurred with natpara [see warnings and precautions (5.6), adverse reactions (6.3)] . risk summary available data with natpara injection use in pregnant women are insufficient to inform a drug associated risk of birth defects, miscarriage or adverse maternal or fetal out

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - amiodarone hydrochloride - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - amiodarone hydrochloride - oral tablet - 100mg